Mutations Are Associated with Higher CD8+ T-Cell Percentage and Favorable Clinical Outcomes in Patients with T-Cell Acute Lymphoblastic Leukemia
Main Authors: | Cunte Chen, Yuping Zhang, Xiangbo Zeng, Chengwu Zeng, Grzegorz K Przybylski, Yangqiu Li |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2023-12-01
|
Series: | Clinical Medicine Insights: Oncology |
Online Access: | https://doi.org/10.1177/11795549231216427 |
Similar Items
-
TNFAIP3 mutation is an independent poor overall survival factor for patients with T‐cell acute lymphoblastic leukemia
by: Cunte Chen, et al.
Published: (2023-02-01) -
Disulfiram, an aldehyde dehydrogenase inhibitor, works as a potent drug against sepsis and cancer via NETosis, pyroptosis, apoptosis, ferroptosis, and cuproptosis
by: Dingrui Nie, et al.
Published: (2022-07-01) -
CD117 expression predicted FLT3 mutation in T‐cell acute lymphoblastic leukemia
by: Haijin Wang, et al.
Published: (2024-02-01) -
Higher CD4+CD40+ T cells (Th40 cells) associate with systemic lupus erythematosus activity
by: Lihua Zhu, et al.
Published: (2023-07-01) -
Can CD34+CD38− lymphoblasts, as likely leukemia stem cells, be a prognostic factor in B-cell precursor acute lymphoblastic leukemia in children?
by: Weronika Stolpa, et al.
Published: (2023-08-01)